Bradycardia is defined as a heart rate of less than 50 beats per minute in adults. While a slow heart rate is not always symptomatic (some well-trained athletes, for example, may have resting heart rates below 60 bpm without any adverse effects), severe bradycardia can significantly compromise cardiac output, leading to inadequate tissue perfusion and potentially life-threatening conditions. Therefore, it is crucial to assess not only the heart rate but also the patient's clinical presentation.
Symptoms: The symptoms of symptomatic bradycardia result from decreased cardiac output and inadequate oxygen delivery to the tissues. These may include:
ECG Findings:
Assess if bradycardia is causing symptoms: If the patient is asymptomatic (no signs of poor perfusion), close monitoring is sufficient. However, if symptoms are present, proceed to the next steps.
Administer atropine: Atropine is the first-line pharmacologic treatment for symptomatic bradycardia. It is an anticholinergic medication that blocks the effects of the vagus nerve, increasing heart rate. The recommended dose is 0.5 mg IV every 3โ5 minutes, with a maximum total dose of 3 mg.
Consider pacing: If atropine is ineffective in improving the patient's condition, transcutaneous pacing (TCP) should be initiated. TCP involves placing pacing pads on the patient's chest and delivering electrical impulses to stimulate the heart to contract.
Additional Medications: If TCP is unavailable or ineffective, or while preparing for TCP, consider an infusion of dopamine (2โ20 mcg/kg/min) or epinephrine (2โ10 mcg/min). These medications increase heart rate and improve cardiac contractility.